NL9401958A - Milk product enriched with eggshell flour. - Google Patents
Milk product enriched with eggshell flour. Download PDFInfo
- Publication number
- NL9401958A NL9401958A NL9401958A NL9401958A NL9401958A NL 9401958 A NL9401958 A NL 9401958A NL 9401958 A NL9401958 A NL 9401958A NL 9401958 A NL9401958 A NL 9401958A NL 9401958 A NL9401958 A NL 9401958A
- Authority
- NL
- Netherlands
- Prior art keywords
- calcium
- milk
- eggshell
- product
- flour
- Prior art date
Links
- 235000013336 milk Nutrition 0.000 title claims description 19
- 239000008267 milk Substances 0.000 title claims description 19
- 210000004080 milk Anatomy 0.000 title claims description 19
- 102000002322 Egg Proteins Human genes 0.000 title description 39
- 108010000912 Egg Proteins Proteins 0.000 title description 39
- 210000003278 egg shell Anatomy 0.000 title description 39
- 235000013312 flour Nutrition 0.000 title description 28
- 235000012054 meals Nutrition 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 6
- 235000008939 whole milk Nutrition 0.000 claims description 6
- 108010046377 Whey Proteins Proteins 0.000 claims description 5
- 235000020161 semi-skimmed milk Nutrition 0.000 claims description 5
- 235000020183 skimmed milk Nutrition 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 239000005862 Whey Substances 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- 235000015155 buttermilk Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 159000000003 magnesium salts Chemical class 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 239000011575 calcium Substances 0.000 description 51
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 44
- 229960005069 calcium Drugs 0.000 description 44
- 229910052791 calcium Inorganic materials 0.000 description 44
- 239000000047 product Substances 0.000 description 36
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 12
- 235000013365 dairy product Nutrition 0.000 description 10
- 239000011777 magnesium Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- 210000003608 fece Anatomy 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 description 6
- 235000010216 calcium carbonate Nutrition 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 235000019621 digestibility Nutrition 0.000 description 6
- 235000013351 cheese Nutrition 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000019784 crude fat Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000005913 Maltodextrin Substances 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 102000014171 Milk Proteins Human genes 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229940035034 maltodextrin Drugs 0.000 description 3
- 235000021243 milk fat Nutrition 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 235000013618 yogurt Nutrition 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 235000019740 Vitamins/micromineral premix Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000011950 custard Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 235000011962 puddings Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
- A23C19/068—Particular types of cheese
- A23C19/076—Soft unripened cheese, e.g. cottage or cream cheese
- A23C19/0765—Addition to the curd of additives other than acidifying agents, dairy products, proteins except gelatine, fats, enzymes, microorganisms, NaCl, CaCl2 or KCl; Foamed fresh cheese products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Non-Alcoholic Beverages (AREA)
- Fodder In General (AREA)
Description
Titel: Met eierschalenmeel verrijkt melkproduktTitle: Milk product enriched with eggshell flour
De uitvinding heeft betrekking op voedingsmiddelen diezijn gebaseerd op melkprodukt en, welke voedingsmiddelen eenverhoogd calciumgehalte hebben.The invention relates to foods which are based on milk product and which foods have an increased calcium content.
Het is algemeen bekend dat melkprodukten een wezenlijkebijdrage leveren in de calciumvoorzlening van de mens. Wanneermelkprodukten als enige calciumbron worden toegepast moetevenwel een aanzienlijke hoeveelheid van deze calciumbronworden geconsumeerd. Teneinde de noodzakelijk geachtedagelijkse dosis calcium op te nemen zou men bijvoorbeeld1 tot 1,25 liter melk moeten drinken.It is well known that milk products make an essential contribution to the provision of calcium to humans. However, when milk products are used as the sole source of calcium, a significant amount of this source of calcium must be consumed. For example, in order to absorb the necessary daily dose of calcium, one should drink 1 to 1.25 liters of milk.
Er is een grote groep mensen die slechts weinigzuivelprodukten consumeert. Daarnaast neemt - mede ten gevolgevan de vergrijzing - het aantal mensen toe waarvoor het vanbelang is voldoende calcium op te nemen ter voorkoming vanlichamelijke ongemakken die ontstaan door een tekort aancalciumionen. Een van deze lichamelijke ongemakken isosteoporose.There is a large group of people who consume only few dairy products. In addition - partly as a result of the aging population - the number of people for whom it is important to absorb sufficient calcium is increasing to prevent physical discomfort caused by a shortage of calcium ions. One of these physical discomfort is isosteoporosis.
in het licht van het bovenstaande bestaat er behoefte aanzuivelprodukten, dié met calcium zijn verrijkt.in view of the above, there is a need for dairy products enriched with calcium.
De doelstelling van de onderhavige uitvinding is dan ookte voorzien in op melkprodukten gebaseerde voedingsmiddelenmet een verhoogd calciumgehalte, welke voedingsmiddelenbekende problemen die worden geassocieerd met een lageca 1 ciumopname beogen te voorkomen. Met andere woorden wordtvolgens de uitvinding beoogd smakelijke, in het lichaam goedopneembare zuivelprodukten verrijkt met calcium te bereidenteneinde een hoge calciumopname te garanderen vanuit eenpreventief, profylactisch oogpunt.The object of the present invention is therefore to provide milk-based foods with an increased calcium content, which aim to prevent food-known problems associated with low calcium intake. In other words, according to the invention it is an object of the invention to prepare tasty dairy products enriched with calcium enriched in the body and to guarantee a high calcium absorption from a preventive, prophylactic point of view.
Er zijn reeds zuivelprodukten met een verhoogd calcium¬gehalte bekend, bijvoorbeeld uit de Europese octrooiaanvrage0 449 354. Deze bekende zuivelprodukten worden verrijkt metanorganische calciumzouten, zoals CaC03, CaCl2, Ca(OH)2, enCa3 (P04)2 of organische calciumhoudende verbindingen, zoalscalciumgluconaat, calciumcitraat, calciumlactaat, calcium- malaat, calciumascorbaat, en calciumglycerofosfaat alsmedemengsels daarvan.Dairy products with an elevated calcium content are already known, for example from European patent application 0 449 354. These known dairy products are enriched with inorganic calcium salts, such as CaCO3, CaCl2, Ca (OH) 2, and Ca3 (PO4) 2 or organic calcium-containing compounds, such as calcium gluconate , calcium citrate, calcium lactate, calcium malate, calcium ascorbate, and calcium glycerophosphate as mixtures thereof.
Volgens de uitvinding is nu verrassenderwijs gevonden datwanneer fijn eierschalenmeel als calciurribron voor zuivel-produkten wordt toegepast, een produkt wordt verkregen dat inhet lichaam van de consument een verbeterde calciumresorptieen retentie van de totale calciumfractie geeft in vergelijkingmet de bekende met calcium uit andere calciumbronnen verrijktezuivelprodukten.According to the invention, it has now surprisingly been found that when fine eggshell flour is used as a source of calcium for dairy products, a product is obtained which gives in the body of the consumer an improved calcium absorption and retention of the total calcium fraction compared to the known dairy products enriched with calcium from other calcium sources.
In het algemeen wordt bij preventief gebruik vaneierschalenmeel een dagelijkse inname van ongeveer 3 g calciumgeadviseerd.In general, with preventive use of eggshell flour, a daily intake of about 3 g of calcium is recommended.
Derhalve heeft de uitvinding betrekking op een opmelkprodukten gebaseerd voedingsmiddel dat is aangevuld metaseptisch gewonnen dan wel steriel of kiemarm fijneierschalenmeel.The invention therefore relates to a foodstuff-based foodstuff which is supplemented with aseptically obtained or sterile or low-germ fine egg shell meal.
Bereidingswerkwijzen voor het type eierschalenmeel dat inde produkten volgens de onderhavige uitvinding wordentoegepast zijn bekend. Met name wordt in dezen explicietverwezen naar de Europese octrooiaanvrage o 347 899 en hetAmerikaanse octrooischrift 5.045.323. Hoewel in feiteeierschalenmeel afkomstig van alle soorten vogels kan wordentoegepast, wordt het eierschalenmeel bij voorkeur bereid uitde schalen van kippeëieren. Een typische analyse van eier¬schalenmeel afkomstig van kippeëieren omvat circa 38 %calcium, 0,4 % magnesium en 0,1 % fosfor. Het calcium is inhoofdzaak aanwezig in de vorm van CaC03.Preparation methods for the type of eggshell flour used in the products of the present invention are known. In particular, reference is made explicitly to European patent application o 347 899 and US patent 5,045,323. Although in fact eggshell meal from all kinds of birds can be used, the eggshell meal is preferably prepared from the shells of chicken eggs. A typical analysis of eggshell meal from chicken eggs includes about 38% calcium, 0.4% magnesium and 0.1% phosphorus. The calcium is mainly present in the form of CaCO3.
In EP-A-0 347 899 worden farmaceutische samenstellingenbeschreven voor de behandeling van ziekten of aandoeningen dieveroorzaakt worden door calciumdeficiëntie. Daar waar volgensde onderhavige uitvinding wordt beoogd een profylactischwerkend produkt te verschaffen, is deze octrooiaanvragegericht op meer geneeskundige toepassingen. Er wordt in EP-A-0 347 899 gesteld dat het volgens de bekende werkwijzevervaardigde produkt in poedervorm het meest effectief is enbij voorkeur oraal wordt ingenomen. Deze Europese octrooi¬aanvrage leert niets waaruit de deskundige zou kunnen afleiden dat toepassing van het beschreven eierschalenprodukt inzuivelprodukten leidt tot een verbeterde calciumresorptie enretentie van de totale calciumfractie.EP-A-0 347 899 discloses pharmaceutical compositions for the treatment of diseases or conditions caused by calcium deficiency. Where it is intended according to the present invention to provide a prophylactic active product, this patent application is directed to more medicinal applications. It is stated in EP-A-0 347 899 that the powdered product manufactured according to the known method is the most effective and is preferably taken orally. This European patent application does not teach anything from which the skilled person can deduce that the use of the described eggshell product dairy products leads to an improved calcium absorption and retention of the total calcium fraction.
Het Amerikaanse octrooischrift 3.558.771 past fijneierschalenmeel toe als wondhelend middel dat topicaal wordtaangébracht. Orale toepassing in welke vorm en voor welk doelook wordt niet genoemd noch gesuggereerd.U.S. Patent 3,558,771 employs fine eggshell flour as a wound healing agent applied topically. Oral application in what form and for what purpose is also not mentioned or suggested.
vanwege de aard van het materiaal waaraan heteierschalenprodukt moet worden toegevoegd is het essentieeldat aseptisch gewonnen en/of steriel of kiemarmeierschalenmeel wordt toegevoegd. Het eierschalenmeel hoeftdaartoe slechts fysisch te worden behandeld. Chemischebehandelingen zoals het in aanraking brengen van deeierschalen met sterk basische en/of oxidatieve middelen zoalsdit bijvoorbeeld wordt voorgeschreven in het Canadeseoctrooischrift 728.606 zijn niet noodzakelijk en vanwege extraprocesstappen zelfs ongewenst. Het eierschalenmeel dat volgensde uitvinding wordt toegepast wordt gewonnen onder aseptischeomstandigheden en/of onder kiemafdoding door middel vanthermisatie.due to the nature of the material to which the eggshell product is to be added, it is essential that aseptically recovered and / or sterile or germicidal meal flour is added. The eggshell flour only needs to be physically treated for this purpose. Chemical treatments such as contacting the shell with strong basic and / or oxidizing agents as prescribed for example in Canadian Patent 728,606 are unnecessary and even undesirable due to additional process steps. The eggshell meal used according to the invention is collected under aseptic conditions and / or under germination by means of thermization.
Het volgens de uitvinding met calcium uit eierschalenmeelverrijkte melkprodukt heeft een relatief hoge calciumconcen-tratie of calciumdensiteit. zo is het mogelijk het calcium-gehalte in volle melk zodanig te verhogen dat een volwassenein plaats van ongeveer 1-1,25 liter slechts 500-700 ml melkhoeft te consumeren om de dagelijks benodigde hoeveelheidcalcium op te nemen. Melk-droge-stof bevat circa 1,2 %calcium, 0,1 % magnesium en 1 % fosfor. Het merendeel van hetcalcium is daarbij colloïdaal aanwezig in de vorm vanfosfaten. In melk kunnen hoeveelheden van ongeveer 3 geierschalenmeel op 40 g droge stof worden toegevoegd teneindeeen goed smakend, met calcium verrijkt produkt te verkrijgen.The milk product enriched with calcium from eggshell flour meal according to the invention has a relatively high calcium concentration or calcium density. for example, it is possible to increase the calcium content in whole milk in such a way that an adult, instead of consuming about 1-1.25 liters, only needs 500-700 ml of milk to absorb the daily amount of calcium required. Milk dry matter contains approximately 1.2% calcium, 0.1% magnesium and 1% phosphorus. The majority of the calcium is thereby colloidal in the form of phosphates. In milk, amounts of about 3 eggshell flour to 40 g of dry matter may be added to obtain a good tasting calcium enriched product.
In feite hangt de hoeveelheid eierschalenmeel die in deprodukten volgens de uitvinding kunnen worden toegepast af vande consistentie van het te verrijken produkt en van hetmondgevoel dat het te verrijken produkt geacht wordt tebezitten. Zo zullen gestructureerde of meer viskeuze melkprodukten, zoals yoghurt, kwark, spreads, pudding,mousses, vla en kaas ertoe bijdragen het uitzakken van hetrelatief zware eierschalenmeel tegen te gaan. Voorts mag nietzoveel eierschalenmeel worden toegevoegd dat daardoor een minof meer droog mondgevoel wordt verkregen. Ook deze hoeveelheideierschalenmeel hangt af van het produkt. Zo zal in kwark hetmondgevoel aanzienlijk minder snel veranderen door toevoegenvan veel eierschalenmeel dan in volle melk. Een en ander wordtbovendien beïnvloed door de fijnheid van het eierschalenmeel.In fact, the amount of eggshell flour that can be used in the products of the invention depends on the consistency of the product to be enriched and on the mouthfeel that the product to be enriched is believed to have. For example, structured or more viscous milk products such as yogurt, cottage cheese, spreads, pudding, mousses, custard and cheese will help to prevent the relatively heavy eggshell flour from settling. Furthermore, not so much eggshell flour may be added that it gives a more or less dry mouthfeel. This quantity of eggshell meal also depends on the product. In quark, for example, the mouthfeel will change considerably less quickly by adding much eggshell flour than in whole milk. This is also influenced by the fineness of the eggshell flour.
Zoals boven reeds vermeld, is gevonden dat eierschalen¬meel leidt tot een verbeterde calciumresorptie en retentie vande totale calciumfractie. Dit is aangetoond aan de hand vaneen vergelijking tussen de schijnbare faecale verteerbaar-heidscoëfficiënten zoals deze bij biggen gevonden werden vooreierschalenmeel en calciumcarbonaat. Zoals aan de deskundigebekend is (zie bijvoorbeeld: Swine in biomedical research.Volumes 1, 2 and 3. Plenum Press, New York, 1986. Ed. M.E.Tumbleson), zijn biggen geschikte diermodellen voor humaanvoedingsonderzoek. In met name voorbeeld 7 wordt een en andernader uitgewerkt.As already mentioned above, it has been found that eggshell flour leads to improved calcium absorption and retention of the total calcium fraction. This has been demonstrated by comparing the apparent faecal digestibility coefficients as found in piglets for eggshell meal and calcium carbonate. As is known to those skilled in the art (see, for example: Swine in biomedical research. Volumes 1, 2 and 3. Plenum Press, New York, 1986. Ed. M.E. Tumbleson), piglets are suitable animal models for human nutrition research. In example 7 in particular, a different approach is elaborated.
In een voorkeursuitvoeringsvorm is het produkt volgens deuitvinding tevens verrijkt met een magnesiumzout. Magnesiumdraagt bij aan het handhaven van een enigszins hogere pH vande extracellulaire vloeistoffen in het lichaam. Vanwege dezewat hogere pH zullen calciumfosfaatzouten uit beenderweefselminder snel in oplossing gaan.In a preferred embodiment, the product according to the invention is also enriched with a magnesium salt. Magnesium contributes to the maintenance of a slightly higher pH of the extracellular fluids in the body. Because of this somewhat higher pH, calcium phosphate salts from bone tissue will dissolve less quickly.
Hoewel eierschalenmeel reeds magnesiumionen bevat, moetenvoor het bereiken van een gewenste fysiologische Mg/Ca-verhouding van 1:4 tot 1:12 - onder andere met het oog op eenoptimale calciumretentie - extra Mg-houdende zouten aan de meteierschalen verrijkte zuivelprodukten worden toegevoegd.Although eggshell flour already contains magnesium ions, in order to achieve a desired physiological Mg / Ca ratio of 1: 4 to 1:12 - including for the purpose of optimal calcium retention - additional Mg-containing salts must be added to the metering dishes enriched dairy products.
Bovendien geeft het voordelen wanneer met het oog op eengoede calciumretentie vitamine D aan het met eierschalenmeelverrijkte zuivelprodukt wordt toegevoegd. Eveneens kunnenlactose en een fluoride-ionenbron het maximale effect van decalciumverrijking positief beïnvloeden.In addition, it is advantageous to add vitamin D to the eggshell-enriched dairy product for good calcium retention. Likewise, lactose and a fluoride ion source can positively influence the maximum effect of calcium enrichment.
De melkprodukten die volgens de uitvinding kunnen wordenverrijkt betreffen vloeibare produkten, al dan niet ingeconcentreerde, gestructureerde, hoog visceuze en/ofgefermenteerde vorm.The milk products which can be enriched according to the invention are liquid products, whether or not concentrated, structured, highly viscous and / or fermented form.
Gestructureerde of meer viskeuze melkprodukten, zoalsyoghurt, kwark, spreads, pudding, mousses, vla en kaas dragen,als gezegd, ertoe bij dat het eierschalenmeel niet uitzakt.Structured or more viscous milk products, such as yogurt, cottage cheese, spreads, pudding, mousses, custard and cheese, contribute, as mentioned, to the eggshell flour not sagging.
Het op melkprodukten gebaseerde produkt volgens deuitvinding kan bovendien in poedervorm worden gebracht.Moreover, the milk-based product of the invention can be powdered.
Geschikte melkgrondstoffen voor de bereiding van deprodukten volgens de uitvinding omvatten volle melk, halfvollemelk, ondermelk, room, wei en karnemelk. Daarnaast kunnendaarvan afgeleide derivaten, zoals casernes, weieiwitten,laktose, ontzoute weiprodukten, melkeiwithydrolysaten,melkvetfrakties en boterolie alsmede de genoemde produkten inpoedervorm worden toegepast als basisgrondstof.Suitable milk raw materials for the preparation of the products according to the invention include whole milk, semi-skimmed milk, skimmed milk, cream, whey and buttermilk. In addition, derivatives thereof, such as casernes, whey proteins, lactose, desalinated whey products, milk protein hydrolysates, milk fat fractions and butter oil, as well as the aforementioned powdered products, can be used as basic raw material.
Aan de melkprodukten verrijkt met eierschalenmeel kunnenvoorts bekende toeslagstoffen worden toegevoegd, bijvoorbeeldmicro-ingrediënten als vitaminen, mineralen, smaakstoffen,aminozuren (zoals lysine, arginine, cysteine, methionine),bindmiddelen, emulgatoren, antioxidantia, extra suikers,plantaardige vetten of eiwitten, dextrinen, voedingsvezels,etc.Known additives can be added to the milk products enriched with eggshell flour, for example micro-ingredients such as vitamins, minerals, flavors, amino acids (such as lysine, arginine, cysteine, methionine), binders, emulsifiers, antioxidants, extra sugars, vegetable fats or proteins, dextrins, dietary fiber, etc.
Thans zal de uitvinding aan de hand van de onderstaandevoorbeelden meer in detail worden toegelicht. Tenzij andersvermeld zijn percentages en delen steeds betrokken op hetgewicht van de totale samenstelling.The invention will now be explained in more detail with reference to the examples below. Unless stated otherwise, percentages and parts are always based on the weight of the total composition.
Yoorbeeld lYoorbeeld l
Bereid werd een halfprodukt door in halfvolle melk,eierschalenmeel en maltodextrine MD 20 op te lossen en ditvolgens bekende werkwijzen op een wieldroger te drogen tot eenpoeder. Het verkregen halfprodukt werd afgemengd met eengebruikelijke vitaminen- en mineralen-premix in droge vorm,zodanig dat het eindprodukt omvatte: 68 dln halfvolle melk droge-stof, 5 dln fijn eierschalenmeel, 24 din maltodextrine MD 20 en 3 din vitaminen- en mineralen-premix.A semi-product was prepared by dissolving MD 20 in semi-skimmed milk, eggshell flour and maltodextrin and drying these according to known methods on a wheel dryer to a powder. The resulting semi-finished product was mixed with a conventional vitamin and mineral premix in dry form such that the final product included: 68 parts of semi-skimmed milk dry matter, 5 parts of fine eggshell flour, 24 parts of maltodextrin MD 20 and 3 parts of vitamin and minerals premix. .
Er werd een samenstelling verkregen, die per 100 grambevatte: 20,5 % eiwit, 14 % vet, 2400 mg Ca, 500 mg Mg, 7 mg Fe, 3 mg Zn, 250 Mg Cu, 94 Mg jodide, 500 IU D3, 2500 m9 β-caroteen, 2500 IE vitamine A, 25 mg vitamine E, 50 m9 vitamine K, 2500 m9 vitamine BI, 4500 m9 vitamine B2,18750 m9 niacine, 5000 m9 vitamine B6, 500 m9 foliumzuur, 5000 m9 pantotheenzuur, 5 m9 vitamine B12, 75 m9 biotine en 150mg vitamine C.A composition was obtained containing per 100 grams: 20.5% protein, 14% fat, 2400 mg Ca, 500 mg Mg, 7 mg Fe, 3 mg Zn, 250 Mg Cu, 94 Mg iodide, 500 IU D3, 2500 m9 β-carotene, 2500 IU vitamin A, 25 mg vitamin E, 50 m9 vitamin K, 2500 m9 vitamin BI, 4500 m9 vitamin B2.18750 m9 niacin, 5000 m9 vitamin B6, 500 m9 folic acid, 5000 m9 pantothenic acid, 5 m9 vitamin B12, 75 m9 biotin and 150mg vitamin C.
De verhouding Ca:Mg bedroeg 5:1.voorbeeld IIThe Ca: Mg ratio was 5: 1. Example II
Overeenkomstig voorbeeld I werd door mengen een produktbereid, waarbij werd uitgegaan van halfvolle melkpoeder, eenpoeder bereid door gezamenlijke droging van eierschalenmeel enmaltodextrine op een wieldroger na vooraf oplossen van demaltodextrine en het eierschalenmeel in water, en devitaminen-mineralen-premix in droge vorm.In accordance with Example 1, a product was prepared by mixing, starting with semi-skimmed milk powder, a powder prepared by co-drying eggshell flour and maltodextrin on a wheel dryer after pre-dissolving demaltodextrin and the eggshell flour in water, and the vitamin-minerals premix in dry form.
Er werd in vergelijking met het produkt volgensVoorbeeld I een produkt met een verbeterde stabiliteit enappreciatie verkregen, na toebereiden van dit poeder tot eenmelkoplossing.Compared to the product of Example I, a product with improved stability and appreciation was obtained after preparing this powder into a milk solution.
Voorbeeld IIIExample III
Bereid werd een poedervormig produkt onder drogeafmenging van 6 % volle melkpoeder, 30 % poedervormig produktbereid uit ondermelk en plantaardig vet (raapolie + oleine), 31 % ondermelkpoeder, 20 % ontzoute-weipoeder, 8 % Fibruline R(bevattende oplosbare dieetvezels in de vorm van inuline), 2 %fijn eierschalenmeel en 3 % vitaminen-mineralenpremix.A powdered product was prepared under dry mixing of 6% whole milk powder, 30% powdered product prepared from skimmed milk and vegetable fat (rapeseed oil + olein), 31% skimmed milk powder, 20% desalinated whey powder, 8% Fibruline R (containing soluble dietary fiber in the form of inulin), 2% fine eggshell flour and 3% vitamin-mineral premix.
Het produkt omvatte per 100 gram: 22,5 % eiwit, 12,5 %vet, 8 % dieetvezels, 350 iU's vitamine D3.The product included per 100 grams: 22.5% protein, 12.5% fat, 8% dietary fiber, 350 iUs of vitamin D3.
De verhouding Ca:Mg bedroeg 1:4.The Ca: Mg ratio was 1: 4.
Voorbeeld IVExample IV
Bereid werd een vetarm "mager" kwarkprodukt dat per 100 g10 g melkeiwitten en 3,5 g koolhydraten bevatte. Hieraan werdper 100 g aseptisch 3 g eierschalenmeel onder roeren toege¬voegd tot een homogeen, goed smakend produkt werd verkregen.A low fat "lean" cottage cheese product was prepared containing per 100 g 10 g milk proteins and 3.5 g carbohydrates. 100 g of aseptic 3 g of eggshell flour were added to this with stirring until a homogeneous, good tasting product was obtained.
Vervolgens werd het aldus bereide produkt afgevuld inport ieverpakkingen.Subsequently, the product thus prepared was filled into port packages.
Voorbeeld VExample V
Volgens voorbeeld IV werd in halfvolle yoghurt die per100 g 4 g melkeiwitten, 4 g koolhydraten en 1,5 g melkvetbevatte, 3 g eierschalenmeel per 100 g opgenomen.In Example IV, 3 g eggshell flour per 100 g was included in semi-skimmed yogurt containing per 100 g 4 g milk proteins, 4 g carbohydrates and 1.5 g milk fat.
Voorbeeld VIExample VI
60 dln gesuikerde gecondenseerde volle melk die 8 %melkvet, 20 % vetvrije melk drogestof, 45 % saccharose en 27 %water bevatte, werden onder roeren gemengd met 40 dln van eenmengsel bestaande uit 45 % saccharose, 20 % fijn eierschalen¬meel, 5 % vitaminen- en mineralen-premix en 30 % water tot eenhomogene massa werd verkregen.60 parts of sweetened condensed whole milk containing 8% milk fat, 20% fat-free milk dry matter, 45% sucrose and 27% water were mixed with 40 parts of a mixture consisting of 45% sucrose, 20% fine eggshell flour, 5% with stirring. vitamin and mineral premix and 30% water to a homogeneous mass.
Het aldus bereide produkt werd afgevuld in sticks.The product thus prepared was filled into sticks.
Voorbeeld VIIExample VII
voor het bepalen van de schijnbare verteerbaarheid vancalcium werd de volgende test uitgevoerd op biggen.to determine the apparent digestibility of calcium, the following test was performed on piglets.
Aseptisch eierschalenmeel werd in deze test vergelekenmet calciumcarbonaat met een zuiverheid van meer dan 98 %(complexometrisch bepaald) afkomstig van Boom B.V., Meppel,Nederland.Aseptic eggshell flour in this test was compared with calcium carbonate with a purity of more than 98% (determined complexometrically) from Boom B.V., Meppel, the Netherlands.
14 gecastreerde mannelijke biggen (COFOK), 5 weken oud,ongeveer 10 kg werden in een metabolisch hok met eenTenderfoot-vloer geplaatst. In dit hok werd de temperatuur op24°C ingesteld, terwijl de luchtvochtigheid op een constantniveau werd gehouden. Het metabolische hok werd verlicht metdaglicht en TL-buizen tussen 8 en 17 uur.14 castrated male piglets (COFOK), 5 weeks old, about 10 kg, were placed in a metabolic pen with a Tenfoot floor. In this loft, the temperature was set at 24 ° C, while the humidity was kept at a constant level. The metabolic loft was illuminated with daylight and fluorescent tubes between 8 am and 5 pm.
Na een acclimatiseringstijd van 6 dagen en een pre-testperiode van 10 dagen, werd gedurende 7 dagen de volgendetest uitgevoerd.After an acclimation time of 6 days and a pre-test period of 10 days, the following test was performed for 7 days.
Op basis van hun gewicht en algemene gezondheidstoestandwerden uit de 14 dieren twee groepen van 6 biggen geselec¬teerd. Per groep werd een experimenteel dieet, het ene met 1 %ca1ciumcarbonaat het andere met 1 % eierschalenmeel alsbelangrijkste calciumbron, gegeven. Per dag werden de biggentweemaal gevoed, waarbij zij een hoeveelheid voedsel ontvingendie 2,2 maal zo groot was als hun normale energiebehoefte. Hetvoer werd in een water:voerverhouding van 2,5:1 gegeven en hadde samenstelling als gegeven in tabel 1.Based on their weight and general health conditions, two groups of 6 piglets were selected from the 14 animals. An experimental diet was given per group, one with 1% calcium carbonate and the other with 1% eggshell meal as the main source of calcium. The piglets were fed twice a day, receiving an amount of food that was 2.2 times their normal energy requirement. The feed was given in a water: feed ratio of 2.5: 1 and had the composition as given in Table 1.
Tabel l. Samenstelling van diëten (%)Table 1. Diet composition (%)
Samenstelling van vetmengsel : kokosvet 10 %, talg 35 %,reuzel 35 %, sojaolie 20 %.Composition of fat mixture: coconut fat 10%, tallow 35%, lard 35%, soybean oil 20%.
2> Premix per 1 kg voer: 9000 IU vitamine A, 1800 iu vitamine D3, 40 mg vitamine E, 5 mg riboflavine, 30 mg niacine amide, 12 mg d-pantotheen-zuur, 350 mg cholinechloride, 40 Mg vitamine Bj.2# 3 mgvitamine K, 50 mg vitamine C, l mg foliumzuur, 0,1 mgbiotine, 2,5 mg C0SO4.7H2O, 0,2 mg Na2Se03.5H20, 0,5 mgKI, 400 mg FeSO4-7H20, 80 mg CuSo4.5H20, 70 mg Mn02, 200 mgZnS04.H20, 40 mg Tylosine.2> Premix per 1 kg feed: 9000 IU vitamin A, 1800 iu vitamin D3, 40 mg vitamin E, 5 mg riboflavin, 30 mg niacin amide, 12 mg d-pantothenic acid, 350 mg choline chloride, 40 Mg vitamin Bj. 2 # 3mg Vitamin K, 50mg Vitamin C, 1mg Folic Acid, 0.1mg Biotin, 2.5mg C0SO4.7H2O, 0.2mg Na2Se03.5H20, 0.5mgKI, 400mg FeSO4-7H20, 80mg CuSo4. 5H20, 70mg MnO2, 200mg ZnSO4.H20, 40mg Tylosin.
De faeces van de biggen werden in stomazakken die aan hunanus waren vastgemaakt opgevangen en geanalyseerd, voor debepaling van de schijnbare vertering van calcium werd detotale voedselopname en de totale hoeveelheid faeces per biggemeten. De stomazakken werden dagelijks geleegd.The faeces of the piglets were collected and analyzed in ostomy bags attached to their anus, and the total food intake and the total amount of faeces per piglet were measured to determine the apparent calcium digestion. The stoma bags were emptied daily.
De faeces werden gewogen en bij -20°C opgeslagen tot heteinde van de testperiode. Vervolgens werden de faecesgevriesdroogd, vermalen, gehomogeniseerd, bempnsterd engeanalyseerd op calciumgehalte en vetgehalte volgens bekendetechnieken. Deze gehalten werden teruggerekend naar nattefaecesgehalten.The faeces were weighed and stored at -20 ° C until the end of the test period. The faeces were then lyophilized, ground, homogenized, sampled and analyzed for calcium content and fat content according to known techniques. These levels were recalculated to wet faeces levels.
De verteerbaarheidscoëfficiënten (DC) van Ca en ruw vetwerden berekend op de hoeveelheden Ca en ruw vet in de diëten,de hoeveelheden van deze componenten in de natte faeces, devoedingsopname van de big en de hoeveelheid faeces geprodu¬ceerd door die big. De gemiddelde DC werd per groep bepaald.The digestibility coefficients (DC) of Ca and crude fat were calculated based on the amounts of Ca and crude fat in the diets, the amounts of these components in the wet faeces, the nutritional intake of the piglet and the amount of faeces produced by that piglet. The mean DC was determined per group.
In tabel 2 worden de schijnbare DC's van calcium en ruw vetgetoond.Table 2 shows the apparent DCs of calcium and crude fat.
Tabel 2. Schijnbare faecale verteerbaarheidscoëfficiënten vancalcium en ruw vet in de diëten.Table 2. Apparent faecal digestibility coefficients of calcium and crude fat in the diets.
Waarden gegeven als gemiddelde ± standaarddeviatieValues given as mean ± standard deviation
De verteerbaarheid van calcium is bij de biggen dieeierschalenmeel als calciumbron kregen gevoerd hoger dan bijde biggen die >98% CaC03 kregen. Het eierschalendieet gaf een gelijke verteerbaarheid van de vetfractie als het carbonaat-dieet.The digestibility of calcium was higher in the piglets fed with calcium-rich egg meal than in the piglets fed> 98% CaCO3. The eggshell diet gave an equal digestibility of the fat fraction as the carbonate diet.
Claims (4)
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9401958A NL9401958A (en) | 1994-11-23 | 1994-11-23 | Milk product enriched with eggshell flour. |
CA002206999A CA2206999A1 (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell |
MX9703814A MX9703814A (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell. |
EP95937214A EP0801529A1 (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell |
PL95320341A PL320341A1 (en) | 1994-11-23 | 1995-11-21 | Diary product enriched with finely ground egg-shells |
PCT/NL1995/000396 WO1996015678A1 (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell |
ZA959881A ZA959881B (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell |
CN95196375A CN1066917C (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell |
SK657-97A SK65797A3 (en) | 1994-11-23 | 1995-11-21 | Food on the milk product base enriched with ground eggshell |
BR9509916A BR9509916A (en) | 1994-11-23 | 1995-11-21 | Foods based on milk products |
NZ295758A NZ295758A (en) | 1994-11-23 | 1995-11-21 | Milk based food supplemented with fine-ground egg shell |
SI9520125A SI9520125A (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell |
CZ971564A CZ156497A3 (en) | 1994-11-23 | 1995-11-21 | Eatables based on milk articles with crushed egg shells |
AU39380/95A AU689342B2 (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell |
JP8516752A JPH11504201A (en) | 1994-11-23 | 1995-11-21 | Dairy products fortified with crushed eggshell |
HU9802840A HUT77982A (en) | 1994-11-23 | 1995-11-21 | Milk product enriched with ground eggshell |
FI972188A FI972188A (en) | 1994-11-23 | 1997-05-22 | Milk product enriched with ground egg shell |
NO972357A NO972357L (en) | 1994-11-23 | 1997-05-22 | Milk products used with ground eggshells |
LT97-097A LT4266B (en) | 1994-11-23 | 1997-05-22 | Milk product enriched with ground eggshell |
BG101506A BG101506A (en) | 1994-11-23 | 1997-05-23 | Milk product enriched with ground eggshell |
HK99102958A HK1017828A1 (en) | 1994-11-23 | 1999-07-12 | Milk product enriched with ground eggshell |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9401958A NL9401958A (en) | 1994-11-23 | 1994-11-23 | Milk product enriched with eggshell flour. |
NL9401958 | 1994-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL9401958A true NL9401958A (en) | 1996-07-01 |
Family
ID=19864929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL9401958A NL9401958A (en) | 1994-11-23 | 1994-11-23 | Milk product enriched with eggshell flour. |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0801529A1 (en) |
JP (1) | JPH11504201A (en) |
CN (1) | CN1066917C (en) |
AU (1) | AU689342B2 (en) |
BG (1) | BG101506A (en) |
BR (1) | BR9509916A (en) |
CA (1) | CA2206999A1 (en) |
CZ (1) | CZ156497A3 (en) |
FI (1) | FI972188A (en) |
HK (1) | HK1017828A1 (en) |
HU (1) | HUT77982A (en) |
LT (1) | LT4266B (en) |
MX (1) | MX9703814A (en) |
NL (1) | NL9401958A (en) |
NO (1) | NO972357L (en) |
NZ (1) | NZ295758A (en) |
PL (1) | PL320341A1 (en) |
SI (1) | SI9520125A (en) |
SK (1) | SK65797A3 (en) |
WO (1) | WO1996015678A1 (en) |
ZA (1) | ZA959881B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1002400C2 (en) * | 1996-02-20 | 1997-08-21 | Friesland Brands Bv | Oral calcitonin preparation and method of recovering calcitonin. |
KR20030023208A (en) * | 2001-09-12 | 2003-03-19 | 임봉환 | Watersoluble ionized calcium and fabrication method thereof |
BG108243A (en) * | 2003-10-08 | 2004-03-31 | Георги И. Златанов | Milk delicatessen and method for its preparation |
DE102007022694A1 (en) * | 2007-05-11 | 2008-11-13 | Humana Milchunion Eg | Milk fat milk protein composition to improve calcium absorption |
NL1034964C2 (en) * | 2008-01-28 | 2009-07-30 | Friesland Brands Bv | Method and compositions for the treatment of bone disorders. |
CN111357814A (en) * | 2018-12-25 | 2020-07-03 | 湖北神地农业科贸有限公司 | Method for preparing high-calcium active lactobacillus beverage by fermenting broken rice and eggshell |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5344662A (en) * | 1976-09-30 | 1978-04-21 | Fujishima Daishiro | Food composition rich in calcium |
JPS5991861A (en) * | 1982-11-17 | 1984-05-26 | Bikou:Kk | Calcium granule of nutrient supplementary food |
JPS60259160A (en) * | 1984-06-04 | 1985-12-21 | Seiichi Watanabe | Preparation of eggshell powder |
JPS61199762A (en) * | 1985-03-01 | 1986-09-04 | Erika Kk | Nutritive food of bone cell |
EP0347899A2 (en) * | 1988-06-24 | 1989-12-27 | BIOMIN, akciová spolocnost' | Pharmaceutical compositions on egg shell basis and their preparation and use |
EP0449354A1 (en) * | 1990-03-16 | 1991-10-02 | Friesland (Frico Domo) Coöperatie B.A. | A process for preparing a calcium enriched fermented milk beverage |
JPH06167460A (en) * | 1992-05-29 | 1994-06-14 | Omron Corp | Inspecting apparatus |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558771A (en) | 1968-02-12 | 1971-01-26 | Leslie L Balassa | Process for using eggshell compositions for promoting wound healing |
EP0049354A3 (en) * | 1980-09-08 | 1983-02-23 | Sterling Drug Inc. | Composition for therapeutic virucidal use, and articles and packages containing said composition |
JPS60259161A (en) | 1984-06-02 | 1985-12-21 | Ohashi Hifumi | Preparation of granular food of vitellus |
JPH0691861B2 (en) | 1990-09-18 | 1994-11-16 | クリエーション・バウマン・ジャパン株式会社 | Curtain material fixture |
JPH0576313A (en) * | 1991-09-19 | 1993-03-30 | Nakajima Nouchikusan Kenkyusho:Kk | Production of healthy food using eggshell as raw material |
JP3693359B2 (en) * | 1993-07-21 | 2005-09-07 | マルハ株式会社 | Bone strengthening promoter |
-
1994
- 1994-11-23 NL NL9401958A patent/NL9401958A/en not_active Application Discontinuation
-
1995
- 1995-11-21 BR BR9509916A patent/BR9509916A/en not_active Application Discontinuation
- 1995-11-21 CN CN95196375A patent/CN1066917C/en not_active Expired - Fee Related
- 1995-11-21 SK SK657-97A patent/SK65797A3/en unknown
- 1995-11-21 WO PCT/NL1995/000396 patent/WO1996015678A1/en not_active Application Discontinuation
- 1995-11-21 CA CA002206999A patent/CA2206999A1/en not_active Abandoned
- 1995-11-21 ZA ZA959881A patent/ZA959881B/en unknown
- 1995-11-21 AU AU39380/95A patent/AU689342B2/en not_active Ceased
- 1995-11-21 MX MX9703814A patent/MX9703814A/en unknown
- 1995-11-21 EP EP95937214A patent/EP0801529A1/en not_active Withdrawn
- 1995-11-21 CZ CZ971564A patent/CZ156497A3/en unknown
- 1995-11-21 SI SI9520125A patent/SI9520125A/en unknown
- 1995-11-21 PL PL95320341A patent/PL320341A1/en unknown
- 1995-11-21 HU HU9802840A patent/HUT77982A/en unknown
- 1995-11-21 JP JP8516752A patent/JPH11504201A/en not_active Ceased
- 1995-11-21 NZ NZ295758A patent/NZ295758A/en unknown
-
1997
- 1997-05-22 LT LT97-097A patent/LT4266B/en unknown
- 1997-05-22 NO NO972357A patent/NO972357L/en unknown
- 1997-05-22 FI FI972188A patent/FI972188A/en unknown
- 1997-05-23 BG BG101506A patent/BG101506A/en unknown
-
1999
- 1999-07-12 HK HK99102958A patent/HK1017828A1/en not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5344662A (en) * | 1976-09-30 | 1978-04-21 | Fujishima Daishiro | Food composition rich in calcium |
JPS5991861A (en) * | 1982-11-17 | 1984-05-26 | Bikou:Kk | Calcium granule of nutrient supplementary food |
JPS60259160A (en) * | 1984-06-04 | 1985-12-21 | Seiichi Watanabe | Preparation of eggshell powder |
JPS61199762A (en) * | 1985-03-01 | 1986-09-04 | Erika Kk | Nutritive food of bone cell |
EP0347899A2 (en) * | 1988-06-24 | 1989-12-27 | BIOMIN, akciová spolocnost' | Pharmaceutical compositions on egg shell basis and their preparation and use |
EP0449354A1 (en) * | 1990-03-16 | 1991-10-02 | Friesland (Frico Domo) Coöperatie B.A. | A process for preparing a calcium enriched fermented milk beverage |
JPH06167460A (en) * | 1992-05-29 | 1994-06-14 | Omron Corp | Inspecting apparatus |
Non-Patent Citations (6)
Title |
---|
DATABASE WPI Week 7822, Derwent World Patents Index; AN 78-39549a * |
DATABASE WPI Week 8427, Derwent World Patents Index; AN 84-168194 * |
DATABASE WPI Week 8642, Derwent World Patents Index; AN 86-275073 * |
PATENT ABSTRACTS OF JAPAN vol. 010, no. 136 (C - 347) * |
PATENT ABSTRACTS OF JAPAN vol. 10, no. 230 (C - 365) * |
PATENT ABSTRACTS OF JAPAN vol. 4, no. 77 (C - 013) * |
Also Published As
Publication number | Publication date |
---|---|
ZA959881B (en) | 1996-08-13 |
SI9520125A (en) | 1998-02-28 |
CZ156497A3 (en) | 1997-10-15 |
BG101506A (en) | 1998-01-30 |
AU3938095A (en) | 1996-06-17 |
LT4266B (en) | 1997-12-29 |
AU689342B2 (en) | 1998-03-26 |
CN1066917C (en) | 2001-06-13 |
LT97097A (en) | 1997-09-25 |
CN1204943A (en) | 1999-01-13 |
FI972188A (en) | 1997-07-22 |
BR9509916A (en) | 1997-09-30 |
WO1996015678A1 (en) | 1996-05-30 |
SK65797A3 (en) | 1997-10-08 |
CA2206999A1 (en) | 1996-05-30 |
NO972357L (en) | 1997-07-22 |
HK1017828A1 (en) | 1999-12-03 |
EP0801529A1 (en) | 1997-10-22 |
NZ295758A (en) | 1998-09-24 |
PL320341A1 (en) | 1997-09-29 |
MX9703814A (en) | 1997-12-31 |
HUT77982A (en) | 1999-03-29 |
FI972188A0 (en) | 1997-05-22 |
NO972357D0 (en) | 1997-05-22 |
JPH11504201A (en) | 1999-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4701329A (en) | Calcium-fortified milk | |
Tjäderhane et al. | A high sucrose diet decreases the mechanical strength of bones in growing rats | |
DE69937882T2 (en) | FOOD COMPOSITION AND METHOD FOR THEIR USE | |
Schaafsma et al. | Eggshell powder, a comparable or better source of calcium than purified calcium carbonate: piglet studies | |
Tsuchita et al. | The effect of casein phosphopeptides on calcium absorption from calcium-fortified milk in growing rats | |
CN106072671B (en) | Dairy product and process | |
CN108029768A (en) | A kind of baby formula milk powder containing lactoferrin and probiotics and preparation method thereof | |
CN101969792A (en) | Methods and compositions for the treatment of bone conditions | |
JP6758285B2 (en) | Whey protein micelle-pectin complex and body muscle protein synthesis | |
EP2114174A2 (en) | Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent | |
RU2468610C2 (en) | Composition of milk fat and milk protein preferably etherified with palmitinic acid for calcium assimilation improvement | |
EP2382874A1 (en) | Amino acid supplementation for a healthy microbiota ecosystem | |
WO2007009529A2 (en) | Calcium-peptide component | |
US20040052918A1 (en) | High energy complete food or nutritional supplement, method for preparing same and uses thereof | |
NL9401958A (en) | Milk product enriched with eggshell flour. | |
Pointillart et al. | Availability of calcium from skim milk, calcium sulfate and calcium carbonate for bone mineralization in pigs | |
Hirasawa et al. | Effect of 1α-hydroxyvitamin D 3 and egg-shell calcium on bone metabolism in ovariectomized osteoporotic model rats | |
US20170295836A1 (en) | Nutritional powders comprising spray dried hmb | |
JP4131443B2 (en) | Anti-osteoporosis composition | |
Roberson et al. | Hypercalcemia and hypervitaminosis D in two lambs | |
JP3560309B2 (en) | Calcium absorption promoting nutritional composition | |
Tyagi et al. | Chelated mineral supplementation in lactating sahiwal cows: effects on performance, biochemical attributes, immune and antioxidant status | |
Kashyap | Ankit Kashyap, AK Santra, OP Dinani, Nishma Singh, Rupal Pahak, Subhrajit Das and Anupam Soni | |
KR20050011989A (en) | Yogurt-based supplement with condonopsis lanceolata trautv | |
EP4401578A1 (en) | Chondroprotective nutraceutical composition and method of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1B | A search report has been drawn up | ||
BV | The patent application has lapsed |